Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Azuma

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
No to Hattatsu = Brain and Development|March 1, 1993
[Effect of ethyl loflazepate on age-dependent epileptic encephalopathy]T Ohira, A Azuma, I Matsuda
Molecular Pharmacology|March 22, 2001
2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrestA Azuma, P Huang, A Matsuda, et al.
The Journal of Antibiotics|March 1, 1977
Isolation and properties of beta-lactamase-less mutants from clinically important gram-negative bacteriaH Ohmori, A Azuma, Y Suzuki, et al.
Biochemical Pharmacology|May 30, 2001
Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC)A Azuma, P Huang, A Matsuda, et al.
Circulation|March 30, 1999
Images in cardiovascular medicine. Right ventricular ischemia by exercise-induced coronary spasm of the right ventricular branchH Sugihara, N Kinoshita, A Azuma, et al.
Bioorganic & Medicinal Chemistry|January 7, 1998
Tumor necrosis factor-alpha production-inhibiting activity of phthalimide analogues on human leukemia THP-1 cells and a structure-activity relationship studyH Miyachi, A Ogasawara, A Azuma, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1977
Factors involved in beta-lactam antibiotic resistance in Pseudomonas aeruginosaH Ohmori, A Azuma, Y Suzuki, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of actionA Azuma, A Matsuda, T Sasaki, et al.
QJM : Monthly Journal of the Association of Physicians|August 2, 2013
The connected health of cardiovascular medicine: current status and future directionsA Ansary, A Azuma, R Komatireddy, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|January 1, 1989
Low-loss ZnO optical waveguides for SAW-AO applicationsM S Wu, A Azuma, T Shiosaki, et al.
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
No to Hattatsu = Brain and Development|March 1, 1993
[Effect of ethyl loflazepate on age-dependent epileptic encephalopathy]T Ohira, A Azuma, I Matsuda
Molecular Pharmacology|March 22, 2001
2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrestA Azuma, P Huang, A Matsuda, et al.
The Journal of Antibiotics|March 1, 1977
Isolation and properties of beta-lactamase-less mutants from clinically important gram-negative bacteriaH Ohmori, A Azuma, Y Suzuki, et al.
Biochemical Pharmacology|May 30, 2001
Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC)A Azuma, P Huang, A Matsuda, et al.
Circulation|March 30, 1999
Images in cardiovascular medicine. Right ventricular ischemia by exercise-induced coronary spasm of the right ventricular branchH Sugihara, N Kinoshita, A Azuma, et al.
Bioorganic & Medicinal Chemistry|January 7, 1998
Tumor necrosis factor-alpha production-inhibiting activity of phthalimide analogues on human leukemia THP-1 cells and a structure-activity relationship studyH Miyachi, A Ogasawara, A Azuma, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1977
Factors involved in beta-lactam antibiotic resistance in Pseudomonas aeruginosaH Ohmori, A Azuma, Y Suzuki, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of actionA Azuma, A Matsuda, T Sasaki, et al.
QJM : Monthly Journal of the Association of Physicians|August 2, 2013
The connected health of cardiovascular medicine: current status and future directionsA Ansary, A Azuma, R Komatireddy, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|January 1, 1989
Low-loss ZnO optical waveguides for SAW-AO applicationsM S Wu, A Azuma, T Shiosaki, et al.
Pageof 19